| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41388-018-0446-2 |
| P698 | PubMed publication ID | 30166591 |
| P50 | author | Bramanandam Manavathi | Q73039730 |
| P2093 | author name string | Ramakrishna Sistla | |
| Roshan M Borkar | |||
| Jayathirtha Rao Vaidya | |||
| Dinesh Thummuri | |||
| Jagadeesh Kumar Gangasani | |||
| Lalita Guntuku | |||
| Srinivas Ragampeta | |||
| Naidu G M Vegi | |||
| P2860 | cites work | p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy | Q24312147 |
| Inhibition of macroautophagy triggers apoptosis | Q24338482 | ||
| Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells | Q24607826 | ||
| Chloroquine and hydroxychloroquine for cancer therapy | Q26827797 | ||
| The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics | Q27010154 | ||
| Autophagy in cancer metastasis | Q38946182 | ||
| Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells. | Q39004520 | ||
| Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors. | Q39378223 | ||
| A high content screening assay for identifying lysosomotropic compounds | Q39615924 | ||
| Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor | Q40290597 | ||
| Anticancer effect of celastrol on human triple negative breast cancer: possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways | Q41146978 | ||
| Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A. | Q41615114 | ||
| Cathepsin B launches an apoptotic exit effort upon cell death-associated disruption of lysosomes | Q41827502 | ||
| Massive cell vacuolization induced by organic amines such as procainamide. | Q41914416 | ||
| Inhibition of autophagy by chloroquine induces apoptosis in primary effusion lymphoma in vitro and in vivo through induction of endoplasmic reticulum stress | Q41914515 | ||
| Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. | Q41915692 | ||
| Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors. | Q46254435 | ||
| 1,3,5-Triazines: A promising scaffold for anticancer drugs development | Q50091117 | ||
| Discovery of triazine-benzimidazoles as selective inhibitors of mTOR | Q27666874 | ||
| p62/SQSTM1 functions as a signaling hub and an autophagy adaptor | Q28081418 | ||
| Triple-negative breast cancer: an unmet medical need | Q28304281 | ||
| Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells | Q28478256 | ||
| Methods in mammalian autophagy research | Q29547276 | ||
| Regulation mechanisms and signaling pathways of autophagy | Q29547416 | ||
| Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis | Q29617725 | ||
| Role of autophagy in cancer | Q29620348 | ||
| A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme | Q33416266 | ||
| Role of autophagy in cisplatin resistance in ovarian cancer cells | Q33761338 | ||
| Commentary. Lysosomotropic agents | Q34214505 | ||
| Multiple functions of BCL-2 family proteins | Q34326024 | ||
| Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering | Q34384711 | ||
| Principles and current strategies for targeting autophagy for cancer treatment | Q34787732 | ||
| The contribution of lysosomotropism to autophagy perturbation | Q35054164 | ||
| The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update | Q35135739 | ||
| Autophagy as a modulator and target in prostate cancer | Q35557084 | ||
| Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells | Q35609829 | ||
| Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers | Q35852989 | ||
| Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency | Q35991524 | ||
| Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages | Q36205312 | ||
| Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances | Q36205315 | ||
| Lysosomes and endoplasmic reticulum: targets for improved, selective anticancer therapy | Q36213403 | ||
| Cysteine cathepsins: multifunctional enzymes in cancer | Q36600996 | ||
| The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair. | Q36893137 | ||
| Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors | Q37011768 | ||
| Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment | Q37299613 | ||
| Lysosomal involvement in cell death and cancer. | Q37307183 | ||
| Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms. | Q37556841 | ||
| Autophagy is a therapeutic target in anticancer drug resistance. | Q37773489 | ||
| Lysosomal-mitochondrial cross-talk during cell death | Q37778889 | ||
| Hydroxychloroquine: from malaria to autoimmunity | Q37827403 | ||
| Identification of Novel Vacuolin-1 Analogues as Autophagy Inhibitors by Virtual Drug Screening and Chemical Synthesis. | Q38677621 | ||
| Synthesis of C5-tethered indolyl-3-glyoxylamide derivatives as tubulin polymerization inhibitors. | Q38718972 | ||
| Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice | Q38719300 | ||
| P433 | issue | 4 | |
| P921 | main subject | autophagy | Q288322 |
| triple-negative breast cancer | Q7843332 | ||
| P304 | page(s) | 581-595 | |
| P577 | publication date | 2018-08-30 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | IITZ-01, a novel potent lysosomotropic autophagy inhibitor, has single-agent antitumor efficacy in triple-negative breast cancer in vitro and in vivo | |
| P478 | volume | 38 |
| Q90750125 | Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities |
| Q98179322 | Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infection |
| Q93164897 | Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy |
| Q90327160 | Yeast β-D-glucan exerts antitumour activity in liver cancer through impairing autophagy and lysosomal function, promoting reactive oxygen species production and apoptosis |
Search more.